Literature DB >> 18650361

Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.

Mignon du Plessis1, Anne von Gottberg, Cheryl Cohen, Linda de Gouveia, Keith P Klugman.   

Abstract

Neisseria meningitidis strains (meningococci) with decreased susceptibility to penicillin (MICs, >0.06 microg/ml) have been reported in several parts of the world, but the prevalence of such isolates in Africa is poorly described. Data from an active national laboratory-based surveillance program from January 2001 through December 2005 were analyzed. A total of 1,897 cases of invasive meningococcal disease were reported, with an average annual incidence of 0.83/100,000 population. Of these cases, 1,381 (73%) had viable isolates available for further testing; 87 (6%) of these isolates tested intermediately resistant to penicillin (Pen(i)). Pen(i) meningococcal isolates were distributed throughout all provinces and age groups, and there was no association with outcome or human immunodeficiency virus infection. The prevalence of Pen(i) was lower in serogroup A (7/295; 2%) than in serogroup B (24/314; 8%), serogroup C (9/117; 8%), serogroup Y (22/248; 9%), or serogroup W135 (25/396; 6%) (P = 0.02). Pulsed-field gel electrophoresis grouped 63/82 Pen(i) isolates into nine clusters, mostly according to serogroup. The clustering of patterns from Pen(i) isolates was not different from that of penicillin-susceptible isolates. Twelve sequence types were identified among 18 isolates arbitrarily selected for multilocus sequence typing. DNA sequence analysis of the penA gene identified 26 different alleles among the Pen(i) isolates. Intermediate penicillin resistance is thus widespread among meningococcal serogroups, has been selected in a variety of lineages, and, to date, does not appear to be associated with increased mortality. This is the first report describing the prevalence and molecular epidemiology of Pen(i) meningococcal isolates from sub-Saharan Africa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650361      PMCID: PMC2566094          DOI: 10.1128/JCM.00221-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.

Authors:  N E Rosenstein; S A Stocker; T Popovic; F C Tenover; B A Perkins
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

2.  Laboratory surveillance for Haemophilus influenzae type B meningococcal, and pneumococcal disease. Haemophilus Surveillance Working Group.

Authors:  R E Huebner; K P Klugman; U Matai; R Eggers; G Hussey
Journal:  S Afr Med J       Date:  1999-09

3.  Penicillin-resistant Neisseria meningitidis in southern Africa.

Authors:  P Botha
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

4.  Prevalence of moderate penicillin resistant invasive Neisseria meningitidis infection in Scotland, 1994-9.

Authors:  M H Kyaw; J C Bramley; S Clark; P Christie; I G Jones; H Campbell
Journal:  Epidemiol Infect       Date:  2002-04       Impact factor: 2.451

Review 5.  Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989).

Authors:  J A Sáez-Nieto; R Lujan; S Berrón; J Campos; M Viñas; C Fusté; J A Vazquez; Q Y Zhang; L D Bowler; J V Martinez-Suarez
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

6.  Insertion of an extra amino acid is the main cause of the low affinity of penicillin-binding protein 2 in penicillin-resistant strains of Neisseria gonorrhoeae.

Authors:  J A Brannigan; I A Tirodimos; Q Y Zhang; C G Dowson; B G Spratt
Journal:  Mol Microbiol       Date:  1990-06       Impact factor: 3.501

7.  Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina.

Authors:  C R Woods; A L Smith; B L Wasilauskas; J Campos; L B Givner
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

8.  Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group.

Authors:  L A Jackson; F C Tenover; C Baker; B D Plikaytis; M W Reeves; S A Stocker; R E Weaver; J D Wenger
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

9.  Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy.

Authors:  P Rådström; A Bäckman; N Qian; P Kragsbjerg; C Påhlson; P Olcén
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

10.  Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991.

Authors:  L A Jackson; J D Wenger
Journal:  MMWR CDC Surveill Summ       Date:  1993-06-04
View more
  18 in total

1.  Population snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008.

Authors:  Mignon du Plessis; Chivonne Moodley; Kedibone M Mothibeli; Azola Fali; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

2.  Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Authors:  Elizabeth M Brown; David N Fisman; Steven J Drews; Sharon Dolman; Prasad Rawte; Shirley Brown; Frances Jamieson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

Review 3.  Novel classes of antibiotics or more of the same?

Authors:  Anthony R M Coates; Gerry Halls; Yanmin Hu
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

4.  Antimicrobial resistance surveillance systems: Are potential biases taken into account?

Authors:  Olivia Rempel; Johann Dd Pitout; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

5.  Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.

Authors:  Chivonne Moodley; Mignon du Plessis; Kedibone Ndlangisa; Linda de Gouveia; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

6.  Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility.

Authors:  Sophie Bertrand; Françoise Carion; René Wintjens; Vanessa Mathys; Raymond Vanhoof
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

7.  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Authors:  Sara Thulin Hedberg; Hans Fredlund; Pierre Nicolas; Dominique A Caugant; Per Olcén; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams.

Authors:  Nouria Belkacem; Eva Hong; Ana Antunes; Aude Terrade; Ala-Eddine Deghmane; Muhamed-Kheir Taha
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

10.  Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.

Authors:  Ana Belén Ibarz-Pavón; Ana Paula Lemos; Maria Cecilia Gorla; Mabel Regueira; Jean-Marc Gabastou
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.